https://www.fidiapharma.eg/newsroom/fidia-announces-expansion-of-its-affiliate-network-worldwide/ 2022-03-14T13:19:14+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Corporate_01-scaled.jpg https://www.fidiapharma.eg/newsroom/latest-results-on-oncofidp-b-at-the-american-urological-associations-2019-annual-meeting/ 2022-03-14T13:19:14+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Research_01-scaled.jpg https://www.fidiapharma.eg/newsroom/top-quality-pharma-grade-hyaluronic-acid-available-from-fidia/ 2022-03-14T13:19:14+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/01/Products_03.jpg https://www.fidiapharma.eg/newsroom/fidia-signed-a-binding-agreement-with-sanofi-for-the-acquisition-of-a-sanofi-portfolio-of-anti-inflammatory-drugs/ 2022-03-14T13:20:07+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Corporate_04-scaled.jpg https://www.fidiapharma.eg/newsroom/fidia-celebrates-its-75th-anniversary-not-a-destination-but-just-one-leg-of-a-journey-that-is-going-faster-than-ever/ 2022-03-15T21:28:41+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/03/readyforthefuture_eng.jpeg https://www.fidiapharma.eg/newsroom/fidia-announces-further-expansion-of-its-presence-in-europe/ 2022-03-16T14:42:26+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Corporate_04-scaled.jpg https://www.fidiapharma.eg/newsroom/fidia-announces-the-fda-orphan-drug-designation-for-oncofid-for-the-treatment-of-malignant-mesothelioma-the-cancer-caused-by-exposure-to-asbestos/ 2022-05-30T07:38:40+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Research_04-scaled.jpg https://www.fidiapharma.eg/newsroom/fidia-farmaceutici-enters-the-polish-market/ 2023-03-10T17:51:34+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Corporate_05-scaled.jpg https://www.fidiapharma.eg/newsroom/fidia-farmaceutici-wins-2023-best-aesthetic-regenerative-medicine-product-award/ 2023-04-20T13:13:24+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/03/AESTHCARE_2_Foto-DX-Copy@2x.jpg https://www.fidiapharma.eg/newsroom/fidia-farmaceutici-11-growth-in-2022-turnover-of-e412-million/ 2023-06-05T14:29:19+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Corporate_01-scaled.jpg https://www.fidiapharma.eg/newsroom/fidia-obtains-certification-for-gender-equality-in-italy/ 2024-04-03T12:03:39+00:00 https://www.fidiapharma.eg/wp-content/uploads/2021/10/quality-control.jpg https://www.fidiapharma.eg/newsroom/fidia-farmaceutici-enters-into-definitive-agreement-for-its-most-important-acquisition-ever-and-confirms-a-double-digit-growth-trend-in-2023/ 2024-06-04T12:53:08+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Corporate_01-scaled.jpg https://www.fidiapharma.eg/newsroom/fidia-farmaceutici-revenues-exceed-e500-million-in-2024/ 2025-05-19T19:57:29+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/02/Corporate_04-scaled.jpg https://www.fidiapharma.eg/newsroom/diversity-equity-inclusion-fidia-launches-its-manifesto-for-inclusive-language/ 2025-06-03T21:00:01+00:00 https://www.fidiapharma.eg/wp-content/uploads/2025/06/DiversityInclusion_991x665.jpg https://www.fidiapharma.eg/newsroom/fidia-a-new-department-for-the-production-of-biological-medicinal-products-and-a-training-center-for-specialist-training/ 2025-07-17T08:05:36+00:00 https://www.fidiapharma.eg/wp-content/uploads/2025/07/inaugurazione-farmaci-biologici.jpg https://www.fidiapharma.eg/newsroom/two-new-acquisitions-in-europe-in-the-uk-and-romania/ 2025-09-03T10:29:30+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/03/Fidia_esterni-ingresso_Fidiafarmaceuticispa-scaled.jpg https://www.fidiapharma.eg/newsroom/fidia-farmaceutici-among-the-best-employers-for-women-in-italy/ 2025-09-18T15:54:21+00:00 https://www.fidiapharma.eg/wp-content/uploads/2025/09/BestEmployersWomen.jpg https://www.fidiapharma.eg/newsroom/fidia-among-the-best-workplaces-in-italy-major-leap-forward-in-the-2026-italys-best-employers-ranking/ 2025-10-23T14:57:35+00:00 https://www.fidiapharma.eg/wp-content/uploads/2025/10/BestEmployees.jpg https://www.fidiapharma.eg/newsroom/fidia-among-the-top-italian-companies-recognized-at-deloitte-privates-best-managed-companies-award/ 2025-11-11T22:08:52+00:00 https://www.fidiapharma.eg/newsroom/advancing-joint-care-worldwide-hymovis-one-receives-fda-approval/ 2026-03-19T17:16:48+00:00 https://www.fidiapharma.eg/wp-content/uploads/2022/04/JOINTCARE_Foto-DX2x.jpg https://www.fidiapharma.eg/newsroom/fidia-renews-its-gender-equality-certification-in-italy-reinforcing-its-commitment-to-diversity-equity-and-inclusion/ 2026-03-19T17:58:59+00:00 https://www.fidiapharma.eg/wp-content/uploads/2026/03/2413_DSC_0013.jpg https://www.fidiapharma.eg/newsroom/fidia-farmaceutici-revenues-to-reach-e538-million-in-2025-up-5-5-y-y/ 2026-06-19T09:53:34+00:00 https://www.fidiapharma.eg/wp-content/uploads/2026/06/Fidia_esterni-ingresso_Fidiafarmaceuticispa-scaled-1.jpg